Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Autor: Grivas, P, Khaki, AR, Wise-Draper, TM, French, B, Hennessy, C, Hsu, C-Y, Shyr, Y, Li, X, Choueiri, TK, Painter, CA, Peters, S, Rini, BI, Thompson, MA, Mishra, S, Rivera, DR, Acoba, JD, Abidi, MZ, Bakouny, Z, Bashir, B, Bekaii-Saab, T, Berg, S, Bernicker, EH, Bilen, MA, Bindal, P, Bishnoi, R, Bouganim, N, Bowles, DW, Cabal, A, Caimi, PF, Chism, DD, Crowell, J, Curran, C, Desai, A, Dixon, B, Doroshow, DB, Durbin, EB, Elkrief, A, Farmakiotis, D, Fazio, A, Fecher, LA, Flora, DB, Friese, CR, Fu, J, Gadgeel, SM, Galsky, MD, Gill, DM, Glover, MJ, Goyal, S, Grover, P, Gulati, S, Gupta, S, Halabi, S, Halfdanarson, TR, Halmos, B, Hausrath, DJ, Hawley, JE, Hsu, E, Huynh-Le, M, Hwang, C, Jani, C, Jayaraj, A, Johnson, DB, Kasi, A, Khan, H, Koshkin, VS, Kuderer, NM, Kwon, DH, Lammers, PE, Li, A, Loaiza-Bonilla, A, Low, CA, Lustberg, MB, Lyman, GH, McKay, RR, McNair, C, Menon, H, Mesa, RA, Mico, V, Mundt, D, Nagaraj, G, Nakasone, ES, Nakayama, J, Nizam, A, Nock, NL, Park, C, Patel, JM, Patel, KG, Peddi, P, Pennell, NA, Piper-Vallillo, AJ, Puc, M, Ravindranathan, D, Reeves, ME, Reuben, DY, Rosenstein, L, Rosovsky, RP, Rubinstein, SM, Salazar, M, Schmidt, AL, Schwartz, GK

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology, vol 32, iss 6

BackgroundPatients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::32464797f1049465c364360d3ca626d5
https://escholarship.org/uc/item/49m429m0

Characterization of time toxicity in older patients with metastatic breast cancer.

Autor: Atre SY; Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT, USA. swarali.atre@gmail.com., Soulos PR; Associate Director, COPPER Center, Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, USA., Kuderer NM; Advanced Cancer Research Group, Seattle, WA, USA., Gross CP; Section of General Medicine, Department of Medicine and Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, USA., Baum LVM; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Dinan MA; Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT, USA., Lustberg MB; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Oct; Vol. 207 (3), pp. 541-550. Date of Electronic Publication: 2024 May 31.

Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations.

Autor: Hart NH; Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia.; Caring Futures Institute, College of Nursing and Health Science, Flinders University, Adelaide, SA, Australia.; Exercise Medicine Research Institute, School of Medical and Health Science, Edith Cowan University, Perth, WA, Australia.; Cancer and Palliative Care Outcomes Centre, School of Nursing, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Institute for Health Research, The University of Notre Dame Australia, Perth, WA, Australia., Nekhlyudov L; Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Smith TJ; Division of General Internal Medicine and Sidney Kimmel Comprehensive Cancer Center, John Hopkins Medical Institutions, Baltimore, MD., Yee J; Centre for Medical Psychology and Evidence-Based Decision-Making, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Fitch MI; School of Graduate Studies, Faculty of Nursing, University of Toronto, Toronto, ON, Canada., Crawford GB; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.; Northern Adelaide Local Health Network, Adelaide, SA, Australia., Koczwara B; Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.; Flinders Cancer and Innovation Centre, Flinders Medical Centre, Adelaide, SA, Australia., Ashbury FD; VieCure, Clinical and Scientific Division, Greenwood Village, CO.; Department of Oncology, University of Calgary, Calgary, ON, Canada., Lustberg MB; Department of Medicine, School of Medicine, Yale University, New Haven, CT.; Medical Oncology Division, Yale Cancer Centre, New Haven, CT., Mollica M; Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD., Smith AL; The Daffodil Centre and University of Sydney: a joint venture with Cancer Council NSW, Sydney, NSW, Australia., Jefford M; Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Chino F; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Zon R; Michiana Hematology-Oncology, Mishawaka, IN.; Cincinnati Cancer Advisors, Norwood, OH., Agar MR; IMPACCT Research Centre, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia., Chan RJ; Caring Futures Institute, College of Nursing and Health Science, Flinders University, Adelaide, SA, Australia.; Cancer and Palliative Care Outcomes Centre, School of Nursing, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Sep; Vol. 20 (9), pp. 1160-1172. Date of Electronic Publication: 2024 Apr 29.

Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial.

Autor: Melink Z; Department of Human Sciences, The Ohio State University, Columbus, OH, 43210, USA., Lustberg MB; Yale School of Medicine, Center for Breast Cancer, New Haven, CT, 06511, USA., Schnell PM; Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, 43210, USA., Mezzanotte-Sharpe J; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Orchard TS; Department of Human Sciences, The Ohio State University, Columbus, OH, 43210, USA. orchard.6@osu.edu.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Dec; Vol. 208 (3), pp. 605-617. Date of Electronic Publication: 2024 Aug 14.

World Health Organization package of interventions for rehabilitation for cancer: a MASCC-endorsed resource for global action to address unmet rehabilitation needs of people affected by cancer.

Autor: Hart NH; Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia. nicolas.hart@uts.edu.au.; Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia. nicolas.hart@uts.edu.au.; Exercise Medicine Research Institute, School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia. nicolas.hart@uts.edu.au.; Cancer and Palliative Care Outcomes Centre, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia. nicolas.hart@uts.edu.au.; Institute for Health Research, University of Notre Dame Australia, Perth, WA, Australia. nicolas.hart@uts.edu.au., Stout NL; Hematology Oncology Department, Division of Cancer Prevention and Control, West Virginia University Cancer Institute, Morgantown, WV, USA., Haywood D; Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia.; Department of Mental Health, St. Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia., Ashbury FD; Clinical & Scientific Division, VieCure, Greenwood Village, CO, USA.; Department of Oncology, University of Calgary, Calgary, AB, Canada.; Internal Medicine - Medical Oncology, College of Medicine, The Ohio State University, Columbus, OH, USA., Chan RJ; Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.; Cancer and Palliative Care Outcomes Centre, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia., Fitch MI; School of Graduate Studies, Faculty of Nursing, University of Toronto, Toronto, ON, Canada., Jefford M; Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Oncology, Sir Peter MacCallum, University of Melbourne, Melbourne, VIC, Australia., Lustberg MB; Department of Medicine, School of Medicine, Yale University, New Haven, CT, USA.; Medical Oncology Division, Yale Cancer Centre, New Haven, CT, USA., Etemadi Y; Sensory Functions, Disability and Rehabilitation Unit, Department for Noncommunicable Diseases, World Health Organization, Geneva, Switzerland., Rauch A; Sensory Functions, Disability and Rehabilitation Unit, Department for Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jun 07; Vol. 32 (7), pp. 417. Date of Electronic Publication: 2024 Jun 07.